# Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

> **NCT02909933** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 30 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Obesity

## Interventions

- **DRUG:** liraglutide
- **DRUG:** metformin and liraglutide

## Key facts

- **NCT ID:** NCT02909933
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02909933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02909933, "Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02909933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*